NasdaqGS:TMCIMedical Equipment
Treace Medical Concepts Q4 Loss Narrowing Challenges Persistent Bearish Narratives On Profitability
Treace Medical Concepts (TMCI) just wrapped up FY 2025 with Q4 revenue of US$62.5 million and a basic EPS loss of US$0.15, while trailing twelve month figures show revenue of US$212.7 million and a basic EPS loss of US$0.93. The company has seen quarterly revenue move between US$45.1 million and US$68.7 million over the last six reported periods, with basic EPS losses ranging from US$0.01 to US$0.28. This puts the focus squarely on how efficiently that revenue base can eventually support...